Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States ...

Zydus Lifesciences Limited has earned USFDA approval for Niacin Extended-Release Tablets used to treat high cholesterol.

New Delhi: Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the ...

The company on April 11 informed that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) Tablets. Deflazacort is a ...

The group also took issue with PTC Therapeutics' new steroid drug Emflaza (deflazacort), which has a list price of $90,700, and concluded that when compared to prednisone, deflazacort “is ...

The Board of directors of Indian Oil Corporation Limited has recommended a final dividend of 30% for the year 2024-25 i.e. Rs ...

The Board of Directors of Coromandel International Ltd have approved a final dividend of Rs. 6/- per Equity share on the face ...

New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central ...